Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2012-10-26 OCONNELL HOWARD V Director Exercise or conversion +5,000 $37.10 $186K 95,639
2012-10-26 OCONNELL HOWARD V Director Sale −8,000 $71.81 $574K 87,639
2012-10-26 OCONNELL HOWARD V Director Exercise or conversion · Stock Option −5,000 0
2012-10-25 Nusse Roeland Director Grant or award · Stock Option +5,000 5,000
2012-10-25 HIGGINS JOHN L Director Grant or award · Stock Option +5,000 5,000
2012-10-25 HOLBROOK KAREN A Director Grant or award · Stock Option +5,000 5,000
2012-10-25 Dinarello Charles A Director Grant or award · Stock Option +5,000 5,000
2012-10-25 BAUMGARTNER ROBERT V Director Grant or award · Stock Option +5,000 5,000
2012-10-25 STEER RANDOLPH C Director Grant or award · Stock Option +5,000 5,000
2012-10-25 LUCAS ROGER C Director Grant or award · Stock Option +5,000 5,000
2012-10-25 OCONNELL HOWARD V Director Grant or award · Stock Option +5,000 5,000
2012-08-14 VERONNEAU MARCEL VP Hematology Operations Exercise or conversion +475 $51.60 $25K 35,044
2012-08-14 VERONNEAU MARCEL VP Hematology Operations Sale −475 $67.57 $32K 34,569
2012-08-14 VERONNEAU MARCEL VP Hematology Operations Exercise or conversion · Stock Option −475 0
2012-07-31 MELSEN GREGORY J VP Finance and CFO Exercise or conversion +426 $51.60 $22K 426
2012-07-31 MELSEN GREGORY J VP Finance and CFO Exercise or conversion · Stock Option −426 0
2012-07-27 VERONNEAU MARCEL VP Hematology Operations Grant or award · Stock Option +1,097 1,097
2012-07-27 MELSEN GREGORY J VP Finance and CFO Grant or award · Stock Option +1,755 1,755
2011-12-05 OCONNELL HOWARD V Director Gift −350 $66.52 $23K 90,639
2011-11-30 OLAND THOMAS E CEO, President Gift −2,000 $67.49 $135K 1,177,420

Page 74 of 75 · 1,487 trades